The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases
No Thumbnail Available
Date
2009-11
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications
Abstract
QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.
Description
Keywords
Antipsychotic, QTc prolongation, Ziprasidone, Torsade-de-pointes, Schizoaffective disorder, Antipsychotic-drugs, Acute exacerbation, Double-blind, 160 mg/day, Schizophrenia, Safety, Haloperidol, Management, Neurosciences & neurology, Pharmacology & pharmacy, Psychiatry
Citation
Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.